Andreas Hess

Prof. Dr. Andreas Hess

Institute of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nuremberg, Erlangen, Germany

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in NeuroImage
Verified
Journal Article
Open access
LHLuam Hammelrath
Luam Hammelrath
SŠSiniša Škokić
Siniša Škokić
AKArtem Khmelinskii
Artem Khmelinskii
AHAndreas Hess
Andreas Hess
NKNoortje van der Knaap
Noortje van der Knaap
MHMathias Hoehn
Mathias Hoehn
With the wide access to studies of selected gene expressions in transgenic animals, mice have become the dominant species as cerebral disease models. Many of these studies are performed on animals of not more than eight weeks, declared as adult animals. Based on the earlier reports that full brain maturation requires at least three months in rats, there is a clear need to discern the corresponding minimal animal age to provide an "adult brain" in mice in order to avoid modulation of disease progression/therapy studies by ongoing developmental changes. For this purpose, we have studied anatomical brain alterations of mice during their first six months of age. Using T2-weighted and diffusion-weighted MRI, structural and volume changes of the brain were identified and compared with histological analysis of myelination. Mouse brain volume was found to be almost stable already at three weeks, but cortex thickness kept decreasing continuously with maximal changes during the first three months. Myelination is still increasing between three and six months, although most dramatic changes are over by three months. While our results emphasize that mice should be at least three months old when adult animals are needed for brain studies, preferred choice of one particular metric for future investigation goals will result in somewhat varying age windows of stabilization.

27 March 2023 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
JGJoanes Grandjean
Joanes Grandjean
GDGabriel Desrosiers-Gregoire
Gabriel Desrosiers-Gregoire
CACynthia Anckaerts
Cynthia Anckaerts
DADiego Angeles-Valdez
Diego Angeles-Valdez
FAFadi Ayad
Fadi Ayad
AHAndreas Hess
Andreas Hess

1 January 2020 in Brain, Behavior, and Immunity
Verified
Journal Article
Open access
SKSilke Kreitz
Silke Kreitz
AZAlice Zambon
Alice Zambon
MRMarianne Ronovsky
Marianne Ronovsky
LBLubos Budinsky
Lubos Budinsky
THThomas H. Helbich
Thomas H. Helbich
DPDaniela D. Pollak
Daniela D. Pollak
Gestational infection constitutes a risk factor for the occurrence of psychiatric disorders in the offspring. Activation of the maternal immune system (MIA) with subsequent impact on the development of the fetal brain is considered to form the neurobiological basis for aberrant neural wiring and the psychiatric manifestations later in offspring life. The examination of validated animal models constitutes a premier resource for the investigation of the neural underpinnings. Here we used a mouse model of MIA based upon systemic treatment of pregnant mice with Poly(I:C) (polyriboinosinic-polyribocytidilic acid), for the unbiased and comprehensive analysis of the impact of MIA on adult offspring brain activity, morphometry, connectivity and function by a magnetic resonance imaging (MRI) approach. Overall lower neural activity, smaller brain regions and less effective fiber structure were observed for Poly(I:C) offspring compared to the control group. The corpus callosum was significantly smaller and presented with a disruption in myelin/ fiber structure in the MIA progeny. Subsequent resting-state functional MRI experiments demonstrated a paralleling dysfunctional interhemispheric connectivity. Additionally, while the overall flow of information was intact, cortico-limbic connectivity was hampered and limbic circuits revealed hyperconnectivity in Poly(I:C) offspring. Our study sheds new light on the impact of maternal infection during pregnancy on the offspring brain and identifies aberrant resting-state functional connectivity patterns as possible correlates of the behavioral phenotype with relevance for psychiatric disorders.

9 August 2018 in Molecular Imaging and Biology
Verified
Journal Article
Closed access
PDF file
AHAndreas Hess
Andreas Hess
RHRukun Hinz
Rukun Hinz
GKGeorgios A. Keliris
Georgios A. Keliris
PBPhilipp Boehm-Sturm
Philipp Boehm-Sturm

19 October 2015 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
MSMarina Sergeeva
Marina Sergeeva
Jürgen RechJürgen Rech
Jürgen Rech
GSGeorg Schett
Georg Schett
AHAndreas Hess
Andreas Hess
Chronic peripheral inflammation in diseases such as rheumatoid arthritis leads to alterations in central pain processing and consequently to mood disorders resulting from sensitization within the central nervous system and enhanced vulnerability of the medial pain pathway. Proinflammatory cytokines such as tumor necrosis factor (TNF) alpha play an important role herein, and therapies targeting their signaling (i.e., anti-TNF therapies) have been proven to achieve good results. However, the phenomenon of rapid improvement in the patients’ subjective feeling after the start of TNFα neutralization remained confusing, because it was observed long before any detectable signs of inflammation decline. Functional magnetic resonance imaging (fMRI), enabling visualization of brain activity upon peripheral immune stimulation with anti-TNF, has helped to clarify this discrepancy. Moreover, fMRI appeared to work as a reliable tool for predicting prospective success of anti-TNF therapy, which is valuable considering the side effects of the drugs and the high therapy costs. This review, which is mainly guided by neuroimaging studies of the brain, summarizes the state-of-the-art knowledge about communication between the immune system and the brain and its impact on subjective well-being, addresses in more detail the outcome of the abovementioned anti-TNF fMRI studies (rapid response to TNFα blockade within the brain pain matrix and differences in brain activation patterns between prospective therapy responders and nonresponders), and discusses possible mechanisms for the latter phenomena and the predictive power of fMRI.

9 March 2009 in Journal of Orthopaedic Research
Verified
Journal Article
Open access
PDF file
KGKolja Gelse
Kolja Gelse
MBMatthias Brem
Matthias Brem
PKPatricia Klinger
Patricia Klinger
AHAndreas Hess
Andreas Hess
BSBernd Swoboda
Bernd Swoboda
AOAlexander Olk
Alexander Olk
The study's objective was to investigate if transplanted chondrocyte or periosteal cell spheroids have influence on ingrowing bone marrow‐derived cells in a novel cartilage repair approach in miniature pigs. Autologous rib chondrocytes or periosteal cells were cultured as spheroids and press‐fitted into cavities that were milled into large, superficial chondral lesions of the patellar joint surface. Within the milled cavities, the subchondral bone plate was either penetrated or left intact (full‐thickness or partial‐thickness cavities). The transplantation of chondrocyte spheroids into full‐thickness cavities induced the formation of additional secondary repair cartilage that exceeded the original volume of the transplanted spheroids. The resulting continuous tissue was rich in proteoglycans and stained positive for type II collagen. Cell labeling revealed that secondarily invading repair cells did not originate from transplanted spheroids, but rather from arroded bone marrow. However, secondary invasion of repair cells was less pronounced following transplantation of periosteal cells and absent in partial‐thickness cavities. According to in vitro analyses, these observations could be ascribed to the ability of chondrocyte spheroids to secrete relevant amounts of bone morphogenetic protein‐2, which was not detected for periosteal cells. Transplanted chondrocyte spheroids exert a dual function: they provide cells for the repair tissue and have a stimulatory paracrine activity, which promotes ingrowth and chondrogenesis of bone marrow‐derived cells. © 2009 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res